skip to Main Content

Novel Nanomedicine Inhibits Progression of Pancreatic Cancer in Mice

Newsfeed image, light gray text on dark gray background
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene — a gene that promotes the development of cancer — and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival. The study may serve as a basis for the development of an effective cocktail of drugs for this deadly disease and other cancers.

The study, which was published in Nature Communications, Read more . . . 

Back To Top